Article

TNF-Induced Recruitment and Activation of the IKK Complex Require Cdc37 and Hsp90

Tularik, Incorporated, Two Corporate Drive, South San Francisco, CA 94080, USA.
Molecular Cell (Impact Factor: 14.46). 03/2002; 9(2):401-10. DOI: 10.1016/S1097-2765(02)00450-1
Source: PubMed

ABSTRACT The IKK complex, containing two catalytic subunits IKKalpha and IKKbeta and a regulatory subunit NEMO, plays central roles in signal-dependent activation of NF-kappaB. We identify Cdc37 and Hsp90 as two additional components of the IKK complex. IKKalpha/IKKbeta/NEMO and Cdc37/Hsp90 form an approximately 900 kDa heterocomplex, which is assembled via direct interactions of Cdc37 with Hsp90 and with the kinase domain of IKKalpha/IKKbeta. Geldanamycin (GA), an antitumor agent that disrupts the formation of this heterocomplex, prevents TNF-induced activation of IKK and NF-kappaB. GA treatment reduces the size of the IKK complex and abolishes TNF-dependent recruitment of the IKK complex to TNF receptor 1 (TNF-R1). Therefore, heterocomplex formation with Cdc37/Hsp90 is a prerequisite for TNF-induced activation and trafficking of IKK from the cytoplasm to the membrane.

0 Followers
 · 
56 Views